Discover how Expedition Medicines, backed by Flagship Pioneering and partnered with Pfizer, uses an AI-driven quantum chemistry platform to create novel therapies for undruggable proteins in oncology and immunology.
Flagship Pioneering introduces Expedition Medicines, backed by $50M funding, employing AI and covalent chemistry to develop new treatments for cancer and immune diseases with Pfizer collaboration.
Explore how chemistry-aware AI, exemplified by Iktos’s Makya platform, is overcoming synthesis challenges in AI drug discovery to accelerate small molecule design and improve drug development.
Explore how artificial intelligence accelerates drug discovery by streamlining target identification, compound screening, and clinical trial design in pharmaceuticals.
How AI is Transforming Drug Discovery in Pharmaceuticals Read More »
Explore how Merck and Siemens combine pharmaceutical R&D and advanced AI platforms to transform drug discovery and development, shaping the future of biopharma innovation.
Merck and Siemens Forge Partnership to Accelerate AI-Driven Drug Discovery Read More »
Discover how the US-UK technology partnership is accelerating AI-driven drug discovery, fostering healthcare innovation, creating jobs, and boosting economic growth.
US-UK Partnership Fuels New Era for AI Drug Discovery Read More »
Explore the impact of artificial intelligence on drug discovery, from speeding up target identification to overcoming challenges in pharmaceutical R&D.
How AI is Transforming Drug Discovery: A New Era in Pharmaceutical Research Read More »
Explore how AI is transforming drug discovery by shortening development timelines, cutting costs, and improving outcomes in pharmaceutical research.
AI Accelerating Drug Discovery: Real-World Advances and Future Outlook Read More »
MIT researchers employ generative AI to identify novel antibiotics effective against MRSA and Neisseria gonorrhoeae, offering new hope against resistant superbugs.
MIT Uses Generative AI to Discover New Antibiotics Targeting Superbugs Read More »
Discover how AI and multiomics are transforming drug discovery by reducing timelines, lowering costs, and improving outcomes. Learn about GATC Health’s innovative approach and its impact on rare diseases and ethical drug development.
AI and Multiomics Accelerate Drug Discovery From Decades to Months Read More »
